tiprankstipranks

BrainStorm granted compliance extension from Nasdaq

BrainStorm (BCLI) Cell Therapeutics announced that it has been granted the exact compliance extension it requested from the Nasdaq Hearings Panel through June 30 to regain compliance with certain continued listing standards of The Nasdaq Capital Market.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1